ArticleClinical ophthalmology (Auckland, N.Z.)2025
The Correlation Between Macular Vessel Density and Its Clinical Parameters in Diabetes Mellitus Type 2.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate macular vessel density using clinical parameters in patients with type 2 diabetes mellitus (DM) without retinopathy. Patients and Methods: This cross-sectional study enrolled 32 participants (63 eyes) aged 40-60 years who met the inclusion criteria. Group 1 included 32 eyes of type 2 DM, whereas the rest had no DM. Ophthalmic examination was performed. Macular vessel density was measured using optical coherence tomography angiography (OCTA) with a 6 × 6 mm scan. Macular vessel density is correlated with patient age, HbA1c values, disease duration, and contrast sensitivity. The data were analyzed using Spearman's rank correlation and an independent Results: Central (foveal area) macular vessel density in the diabetic group (5.36 ± 2.87) was significantly lower than that in healthy participants (7.82 ± 3.05) (p = 0.002). The whole macular vessel density (foveal and parafoveal areas) was also lower in the DM group than in the healthy subjects (15.76 ± 3.38 vs 17.18 ± 1.92) but the difference was not statistically significant (p = 0.070). The age of DM patients has correlated with central (r = -0.522; p = 0.002) and whole macular vessel density (r = -0.369; p = 0.038). HbA1c levels, diabetes duration, and contrast sensitivity were not correlated with macular vessel density. Conclusion: Macular vessel density was lower in DM patients without retinopathy than in healthy subjects. In patients with DM, macular vessel density decreases with increasing age. We failed to find a correlation between macular vessel density and the HbA1c value, disease duration, or contrast sensitivity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.